DURHAM, N.C., February 14, 2025--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants.
MED-EL USA, a leader in implantable hearing solutions, announced that the US Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants. SONNET 3 is the ...
SONNET 3 offers exceptional sound quality, integrated wireless connectivity, and a design optimized for bilateral use DURHAM, N.C., February 14, 2025--(BUSINESS WIRE)--MED-EL USA announced today that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results